$MNSO: Nomura keeps Neutral — domestic recovery is real, but overseas growth just fell off a cliff
- 3Q26 revenue CNY 6.6bn, +6.8% y-y, ahead of consensus CNY 6.4bn; adj. operating profit CNY 998mn, -2.5% y-y but far above consensus CNY 735mn. - Domestic same-store sales grew high-single-digit % y-y in 3Q26 (9M26: mid-single-digit %). The home market is healing. - Overseas is the problem: revenue +1.7% y-y vs +14.9% in 1H26. North America offline growth slowed to +16.8% from +37.0%; overseas inventory hit 271 days (vs 212 a year ago). - Margins: gross margin +0.6pp y-y, wiped out by sales & distribution costs +2.9pp y-y. Nomura sees no margin turnaround in 4Q26. - Valuation: target $12.00 (from $11.70, 6.8% upside) at an unchanged 10.0x forward P/E; the stock trades at 9.7x FY26F P/E. FY26F revenue CNY 24.7bn, +15.0% y-y; FD normalized EPS CNY 8.38, -11.7% y-y.
Unhidea take: overseas was the growth story behind MINISO's premium — at +1.7% with 271 days of inventory, that story is on pause. Inventory ties up cash and forces discounting before it shows in margins. Unhidea take: buybacks of >CNY 1bn (~4.5% of shares) are doing the heavy lifting while normalized EPS still falls 11.7% in FY26F. A cheap stock (9.7x) waiting for an overseas re-acceleration, not a turnaround yet.
Risks: domestic SSS slowdown, overseas uncertainty, intensifying competition. Source: Nomura, 18 Nov 2026. Not financial advice.
$AS: Arc'teryx & Salomon power a 24% beat — Nomura reiterates Buy, TP $48.10 (+65% upside)
- 3Q26 revenue $2.2bn, +24% YoY, vs $2.1bn consensus. Adj. operating profit $357mn, +30% YoY, ahead of consensus. Adj. EPS $0.42 vs $0.35 expected. - Technical Apparel (Arc'teryx) +26% YoY, same-store sales +16%; Outdoor Performance (Salomon) +27% YoY, SSS +28%. Ball & Racquet +12%, but margin fell 2.1pp on Wilson investment. - Guidance raised: FY26 revenue growth to 25.5% (from 24.0%); diluted EPS to $1.34 (from $1.29). A $1bn buyback (~5.7% of market cap) adds a floor. - Shares +3.9% to $30.24 on 17 Nov while the S&P fell ~1%, then +2.3% to $30.95 on 18 Nov (post-report market data). SOTP target implies 14.9x forward EV/EBITDA.
Unhidea take: two brands growing 26–27% with DTC pricing power, plus a buyback floor — the market still prices Amer like a cyclical retailer; Nomura's 65% upside says brand platform. Unhidea take: the Street is split — UBS cut its target to $56, Nomura holds $48.10, both Buy. That gap is the debate: what multiple for a 25% grower at 59.3% gross margin?
Risks: Wilson drag, DTC execution, tariffs/FX, premium-consumer slowdown. Source: Nomura, 18 Nov 2026. Post-report prices: Finnhub/market data. Not financial advice.
Murata (6981.JP): Bernstein sees ~116% upside as AI servers turn a tiny capacitor into a wide moat — target ¥10,500 vs ¥4,855 close on 16 Nov
- Global MLCC market ~$14Bn in 2025, ~4Tn units. Premium is <5% of volume but ~50% of revenue — Murata takes 50% of premium revenue. - Data centers ~13% of MLCC revenue, +33% YoY. Cutting-edge MLCC: 0.2% of volume, 7% of revenue, 8% of margins. - AI-server MLCCs must run 24/7 for 10+ years, near-zero failure — a bar most rivals can't clear at scale. Murata R&D is 9% of revenue vs 4–7% for peers. - Mix shift, not price hikes: Murata MLCC margin seen rising 28% (2025) to 48% (2030E). Every +10% in cutting-edge pricing adds +0.5ppt to group margin. - Bernstein reiterates Outperform, TP ¥10,500. Adj. EPS ¥219.36 in 2026E (+72% YoY), ¥307.95 in 2027E; 22.1x / 15.8x P/E.
Unhidea take: the AI trade has been about GPUs and power — but every AI rack needs thousands of MLCCs that cannot fail. Murata's edge is the boring, certified, yield-driven kind that compounds quietly. Unhidea take: Bernstein gives China 5–10 years to catch up on premium MLCC. The AI buildout is happening now, and the qualified supplier list is effectively two names long — that window is the investment case.
Risks: Murata is reluctant to raise prices, so mix shift must deliver; an AI server slowdown or weak smartphone/auto demand would hit volumes. Source: Bernstein, 17 Nov 2026. Not financial advice.
$NAURA: Bernstein's top pick as China's HBM shortage turns into a DRAM capex boom — target CNY 1,380 implies ~153% upside
- Bernstein raises China WFE TAM to $57/76/108Bn for 2026-28 (was $57/73/101Bn); memory WFE $16.3/28.9/48.7Bn, growing +84%/78%/68% YoY. - HBM shortage is the 2027 bottleneck: DRAM WFE revised up $3.0Bn (2027) and $6.9Bn (2028) after CXMT's post-IPO capex update; YMTC DRAM expansion starts in 2027. - NAURA order growth is 60%+ YoY vs 30% guided; EPS seen rising +58%/+124%/+119% YoY in 2026-28. Piotech orders 100%+ in 9M26. - Localization steps up: mature-logic fabs' local-tool share jumps from <20% to 50%+ next year; Bernstein sees localization at 36%/49% in 2027/28. - NAURA rated Outperform, target CNY 1,380 vs CNY 546.39 close on 16 Nov, at 32x 2028E P/E. AMEC CNY 660 and Piotech CNY 1,200, both Outperform.
Unhidea take: the market is pricing AI sentiment, not the order book — 60%+ order growth in a sector Bernstein says is "clearly not trading on fundamentals" is the disconnect; strong 1Q27 orders would be the re-rating trigger. Unhidea take: HBM is the choke point that makes DRAM capex the most certain spend in semis — memory capacity can't be deferred if China wants AI self-sufficiency, so WFE is the purest localization play and NAURA's broadest portfolio captures the most of it.
Risks: no strong catalyst in 4Q26, near-term volatility; global AI sentiment. Source: Bernstein, 17 Nov 2026. Not financial advice.
$9868.HK: XPeng's overseas cars earn ~2x domestic margins — Morgan Stanley says exports now fund the robot bet. Overweight, HK$70 target, 83% upside vs HK$38.28 close (17 Nov).
Overseas ASP is ~50% above domestic, at ~2x the gross margin. MS expects overseas to be 30% of 4Q26 revenue and over half of gross profit, holding vehicle GpM at 12–13% despite a richer MONA mix.
Production is sold out for months: L03 tops 20k/month, L05 10k/month, with 4+ and 2+ months of backlog, carrying deliveries through the 1Q27 low season.
Robotics is the next leg: auto R&D holds at ~Rmb5bn, robotics R&D rises in 2027, targeting several billion Rmb in revenue and gross profit, funded by positive FCF (Rmb3–4bn annual capex).
MS models 2027E revenue of Rmb103.3bn (+25% YoY) and a first profit in 2028E (EPS Rmb0.23 vs a Rmb0.37 loss in 2027E).
Unhidea take: overseas is the margin engine — every export car does the work of two at home, so the robot bet is funded by exports, not dilution. Unhidea take: watch whether robotics revenue lands in 2027 — until then, XPeng is priced as a carmaker with a robot story.
Risks: competition; cash-flow pressure; slower demand. Source: Morgan Stanley, 17 Nov 2026. Not financial advice.